BECOME MEMBER SUPPORT
Year Cancer type Speaker
Live Webinar Educational Series Virtual Lung Cancer Congress - 12 March 2022
Welcome & Introduction
Lorlatinib as front Line option in ALK+ mNSCLC
Meeting the unmet need in NSCLC patients with MET exon 14 alterations
Video and slides 
CRSF Asco list of publications 
Ongoing studies 